WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services announced yesterday the closing of Bone Biologics (NASDAQ: …
Capital Markets
WallachBeth Capital Announces Pricing Of bioAffinity Technologies IPO at $6.125 Per Unit
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bio-Affinity Technologies, Inc. …
WallachBeth Announces Completion of ABVC BioPharma, Inc. (Nasdaq: ABVC) $4.22 Million Registered Direct Offering
WallachBeth announced the completion of the purchase and sale of 2,000,000 shares of common stock of ABVC BioPharma, Inc. (Nasdaq: ABVC), and warrants to …